Truvestments Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.9K Sell
189
-24
-11% -$6.31K 0.01% 523
2026
Q1
$56.8K Hold
213
– – 0.01% 477
2025
Q4
$53.4K Buy
213
+123
+137% +$32.7K 0.01% 438
2025
Q3
$25.8K Buy
90
+25
+38% +$6.7K ﹤0.01% 546
2025
Q2
$17.1K Buy
+65
New +$15.8K ﹤0.01% 560
2023
Q1
– Sell
-16
Closed -$3.3K – 836
2022
Q4
$3.3K Buy
+16
New +$3.13K ﹤0.01% 624

Other funds holding LH

Truvestments Capital's LH Position: Q2 2026 in Review

Truvestments Capital reduced its Labcorp (LH) stake by 11% in Q2 2026, selling an estimated $6.31K and leaving 189 shares worth $52.9K. The position accounts for 0.01% of the portfolio, ranked #523.

Truvestments Capital first reported a position in LH in Q4 2022 and has held it in 6 quarters since. The position peaked at $56.8K in Q1 2026. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Truvestments Capital held 189 shares of Labcorp worth $52.9K as of Q2 2026.
  • Truvestments Capital sold 24 Labcorp shares in Q2 2026, an estimated $6.31K.
  • Labcorp made up 0.01% of Truvestments Capital's portfolio in Q2 2026, its #523 holding.
  • Truvestments Capital first reported a position in Labcorp in Q4 2022 and has held it in 6 quarters since.
  • Truvestments Capital's Labcorp position peaked at $56.8K in Q1 2026.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.